2022 Guest Lecturers

2022 Urology Guest Lecturers

PHILLIP M. PIERORAZIO, MD, UNIVERSITY OF PENNSYLVANIA Dr. Pierorazio is Chief, Section of Urology, Penn Presbyterian Medical Center Professor of Surgery at the University of Pennsylvania. On June 9, 2022, he presented an engaging lecture on physician and surgeon “Burnout.”

DR. DAVID JARRARD, UNIVERSITY OF WISCONSIN David Jarrard MD is a tenured Professor, Vice Chair for the Department of Urology and Associate Director for the UW Carbone Cancer Center at the University of Wisconsin. He currently serves on prostate cancer guidelines panels for the National Comprehensive Cancer Network (NCCN) and the American Urological Association (AUA). Dr. Jarrard’s clinical work concentrates on advanced Urologic Oncology and improving cancer detection and outcomes

On November 17, 2022, Dr. Jarrard presented to our SKCC MORA group “Exploiting Unique Prostate Cancer Phenotypes To Improve Therapeutic Response”. The MORA (Molecular Oncology Regulation and Approaches) is an SKCC program that includes researchers in the area of prostate, bladder, breast, ovarian and other malignancies.

DR. HERB LEPOR, NYU LANGONE MEDICAL CENTER Our September 29, 2022, our Grand Rounds lecturer was Dr. Herbert Lepor, who presented on the topic of “Focal Therapy for Prostate Cancer.” Dr. Lepor is Professor of Urology, Biochemistry, and Molecular Pharmacology and the Martin Spatz Chairman of the Department of Urology at NYU Langone Health in New York City. His clinical practice is devoted exclusively to the surgical management of prostate cancer. In 1995, Dr. Lepor was awarded the Gold Cystoscope Award by The American Urological Association. Dr. Lepor has served on the editorial boards for four major urological journals and has authored more than 400 peer reviewed articles, 50 book chapters, and 12 books related to prostate cancer, benign prostatic hyperplasia, and the pharmacology of the prostate. Dr. Lepor has been a visiting professor at 30 institutions. Dr. Lepor is a member of the American Association of Genitourinary Surgeons, Clinical Society of the American Association of Genitourinary Surgeons, the American Surgical Association, and the Johns Hopkins University Society of Scholars.

Dr. Sam Chang presented the September 15, 2022, grand rounds titled, “AUA Guidelines for NMIBC: Highlights and Key Points.” Sam S. Chang, MD, MBA, the Patricia and Rodes Hart Endowed Professor of Urologic Surgery and Oncology at Vanderbilt University Medical Center, serves as the first Chief Surgical Officer at the Vanderbilt Ingram Cancer Center. Dr. Chang, a graduate of Princeton University and Justin Potter Scholarship Awardee at Vanderbilt Medical School, completed his uro-oncology fellowship as Chief Fellow at Memorial SloanKettering Cancer Center, New York.

Since his return to Nashville, he has focused on urologic oncology and education and has led efforts in integration of evidence-based medicine in clinical pathways, enhanced national guidelines formulation, improved urologic cancer staging, and promoted multidisciplinary cancer treatment initiatives. He has orchestrated the initiation and expansion of multiple cancer-related treatment protocols at Vanderbilt and elsewhere. Recognized early in his career with a CaPCURE Prostate Cancer Young Investigator award (now Prostate Cancer Foundation Award), Dr. Chang has served as the Chair of the SUO Panel on Hormone Refractory Prostate Cancer, the Chair of the American Joint Committee on Cancer GU Staging Task Force, the Facilitator and ViceChair of the Renal Malignancy Follow-Up AUA Guidelines Panel, the Chair of the AUA/ ASCO/ASTRO/SUO Guidelines on Non Invasive and Invasive Bladder Cancer, and the Chair of the AUA Prostate Cancer Core Curriculum Committee. He was a former member of the AUA Foundation Prostate Advisory Board and is a current member of the NCCN Bladder Cancer Panel, Chair of the AUA Public Policy Panel, member of the Bladder Cancer Advocacy Network (BCAN)’s Scientific Advisory Board, member of the AUA Practice Guidelines Committee, and the Editor in Chief of the American Board of Urology Examination Committee (2021-2024). He was elected (2018-2022) Assistant Secretary of the American Urological Association. In 2021, Dr. Chang was also named as a member of the AUA Task Force on Diversity and Inclusion.

For his academic efforts, he received the SUO’s first-ever Distinguished Service Award and the AUA Gold Cystoscope Award. His mentoring efforts have been recognized with the Society of Women in Urology (SWIU) Christina Manthos Mentoring Award in 2021.

DR. SAM CHANG, VANDERBILT UNIVERSITY

Dr. Sam Chang presented his grand rounds virtually from Vanderbilt Medical Center in Nashville, TN.